<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">337045</id>
  <title nil="true"/>
  <common-name>Methyl 2-[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-4-(propan-2-ylamino)pyrimidine-5-carboxylate</common-name>
  <description>Methyl 2-[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-4-(propan-2-ylamino)pyrimidine-5-carboxylate is a compound with the formula C23H30N8O4. It has an average molecular weight of 482.50 g/mol.</description>
  <cas nil="true"/>
  <pubchem-id>3064569</pubchem-id>
  <chemical-formula>C23H30N8O4</chemical-formula>
  <weight>482.5</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-30T19:44:49Z</created-at>
  <updated-at type="dateTime">2026-08-30T19:44:49Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC(C)NC1=NC(=NC=C1C(=O)OC)N2CCN(CC2)C3=NC4=CC(=C(C=C4C(=N3)N)OC)OC</moldb-smiles>
  <moldb-formula>C23H30N8O4</moldb-formula>
  <moldb-inchi>InChI=1S/C23H30N8O4/c1-13(2)26-20-15(21(32)35-5)12-25-22(29-20)30-6-8-31(9-7-30)23-27-16-11-18(34-4)17(33-3)10-14(16)19(24)28-23/h10-13H,6-9H2,1-5H3,(H2,24,27,28)(H,25,26,29)</moldb-inchi>
  <moldb-inchikey>APJSXLPAKSJKEV-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">482.2390015</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>3.3</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM332938</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>Methyl 2-[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-4-(propan-2-ylamino)pyrimidine-5-carboxylate</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Diazinanes</klass>
  <subklass>Piperazines</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0287493</sync-id>
  <structure-inchikey>APJSXLPAKSJKEV-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>40002001000000000000200000000000002040000000000000000000000000400040001000000000000100000000002000000100000000000000000000000000000000000000000000000000000000000020000000002100080000000000000000080000010000000040000000100000002000020180000000000000000000000800400040000000004020000000000080001000000000000000080400840000000000000000000000040000080000000000000000085000008004000800000180000000000000000000000000008000080000000000000000000000000000000000000000000001000040000000001400000000000020000100000000000021</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAjAAAAJgAAAIABBgBgAAAAAQMGAGAAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:38:16Z</structure-indexed-at>
</compound>
